GlassScriptPhysician profile
Islam Ali Shahin
NPI 1720042070
$72,135.11
in general payments reported to CMS, 2019-2025
25 companies · $636 in 2025
The $636 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $32K · 2021: $13K · 2022: $1,241 · 2023: $6,498 · 2024: $847 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $2,428 · Travel and Lodging: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $2,428.40 |
| Travel and Lodging | $552.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $67,456.37 | 2019-2025 | Sir-Spheres Microspheres |
| Balt USA, LLC | $826.99 | 2021-2025 | Prestige Coil System |
| Boston Scientific Corporation | $733.01 | 2019-2024 | Spyglass Discover |
| Medtronic, INC. | $612.64 | 2021-2025 | Kyphon Express II Kyphopak Tray, Achieve, Emprint |
| Inari Medical, INC. | $472.34 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $443.67 | 2022-2025 | Avs Pl, Spinejack, Flowtriever Catheter, S |
| W. L. Gore & Associates, INC. | $335.86 | 2020-2024 | Gore Viabahn Endoprosthesis |
| Medtronic Vascular, INC. | $267.37 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $194.68 | 2020-2025 | Trek |
| Argon Medical Devices, INC. | $112.93 | 2023-2025 | Clot Management, Clot Management, Cleaner |
| Avenu Medical INC. | $107.16 | 2019 | |
| Angiodynamics, INC. | $104.91 | 2020-2023 | Alphavac |
| Okami Medical, INC. | $99.55 | 2025 | Lobo |
| Covidien LP | $75.24 | 2019 | |
| Abbott Laboratories | $67.79 | 2019-2023 | Jeti Peripheral Catheter |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $50.85 | 2019-2025 | Glidewire |
| Imperative Care, INC | $25.90 | 2025 | Symphony Catheter |
| Philips North America LLC | $25.89 | 2019 | |
| Bard Access Systems, INC. | $22.61 | 2019 | |
| Siemens Medical Solutions USA, INC. | $18.11 | 2022 | |
| Trisalus Life Sciences, INC. | $17.94 | 2023 | Trinav Infusion System |
| Medtronic USA, INC. | $17.40 | 2020 | |
| Cardiva Medical, INC. | $16.69 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.93 | 2021 | |
| Teleflex LLC | $14.28 | 2023 | Arrow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Islam Shahin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.